Add to ORKGThe goal of this research is to develop 64Cu radiolabeled somatostatin-receptor ligands for position emission tomography (PET) imaging and radiotherapy of cancer. Copper-64 radiopharmaceuticals have been used as PET imaging agents for various diseases because of the favorable decay characteristics of 64Cu (t1/2 = 12.7 h; β+ (17.8%); β- (38.4%))
A bifunctional chelator for stably complexing metal radionuclides to tumor-targeting molecules is cr...
The contribution of positron emission tomography (PET) to the drug discovery and development (D3) pi...
At present, various copper radioisotopes are produced by cyclotrons for targeted imaging and treatme...
The goal of this research is to develop 64Cu radiolabeled somatostatin-receptor ligands for position...
This study investigated several somatostatin analogues labeled with copper-64 for imaging and target...
Copper radionuclides are rapidly emerging as potential diagnostic and therapeutic tools in oncology,...
The goal of this dissertation is to evaluate the feasibility of applying 64Cu radiopharmaceuticals i...
The goal of this dissertation is to evaluate the feasibility of applying 64Cu radiopharmaceuticals i...
This study investigated several somatostatin analogues labeled with copper-64 for imaging and target...
Copper is required for cancer cell proliferation and tumor angiogenesis. Copper-64 radionuclide (64C...
Copper is required for cancer cell proliferation and tumor angiogenesis. Copper-64 radionuclide (64C...
Imaging of somatostatin receptor expression is an established technique for staging of neuroendocrin...
The advancement of positron emission tomography (PET) depends on the development of new radiotracers...
Bianca Gutfilen,1 Sergio AL Souza,1 Gianluca Valentini2 1Department of Radiology, School of Medicin...
A bifunctional chelator for stably complexing metal radionuclides to tumor-targeting molecules is cr...
A bifunctional chelator for stably complexing metal radionuclides to tumor-targeting molecules is cr...
The contribution of positron emission tomography (PET) to the drug discovery and development (D3) pi...
At present, various copper radioisotopes are produced by cyclotrons for targeted imaging and treatme...
The goal of this research is to develop 64Cu radiolabeled somatostatin-receptor ligands for position...
This study investigated several somatostatin analogues labeled with copper-64 for imaging and target...
Copper radionuclides are rapidly emerging as potential diagnostic and therapeutic tools in oncology,...
The goal of this dissertation is to evaluate the feasibility of applying 64Cu radiopharmaceuticals i...
The goal of this dissertation is to evaluate the feasibility of applying 64Cu radiopharmaceuticals i...
This study investigated several somatostatin analogues labeled with copper-64 for imaging and target...
Copper is required for cancer cell proliferation and tumor angiogenesis. Copper-64 radionuclide (64C...
Copper is required for cancer cell proliferation and tumor angiogenesis. Copper-64 radionuclide (64C...
Imaging of somatostatin receptor expression is an established technique for staging of neuroendocrin...
The advancement of positron emission tomography (PET) depends on the development of new radiotracers...
Bianca Gutfilen,1 Sergio AL Souza,1 Gianluca Valentini2 1Department of Radiology, School of Medicin...
A bifunctional chelator for stably complexing metal radionuclides to tumor-targeting molecules is cr...
A bifunctional chelator for stably complexing metal radionuclides to tumor-targeting molecules is cr...
The contribution of positron emission tomography (PET) to the drug discovery and development (D3) pi...
At present, various copper radioisotopes are produced by cyclotrons for targeted imaging and treatme...